Medically reviewed by Drugs.com. Last updated on Mar 8, 2022.
Commonly used brand name(s)
In the U.S.
- Mycamine
Available Dosage Forms:
- Powder for Solution
Therapeutic Class: Antifungal
Pharmacologic Class: Glucan Synthesis Inhibitor
Chemical Class: Echinocandin
Uses for micafungin
Micafungin injection is used to help the body overcome serious fungus infections, such as candidemia, acute disseminated candidiasis, candida peritonitis and abscess without meningoencephalitis or ocular dissemination, and esophageal candidiasis. Micafungin injection is also used to prevent candida infections in patients having a stem cell transplant.
Micafungin is available only with your doctor's prescription.
Before using micafungin
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For micafungin, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to micafungin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of micafungin injection to treat candidemia, acute disseminated candidiasis, candida peritonitis and abscess, esophageal candidiasis, and prevent candida infections with stem cell treatment in children 4 months of age and older.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of micafungin injection to treat candidemia, acute disseminated candidiasis, candida peritonitis and abscess without meningoencephalitis or ocular dissemination in children younger than 4 months of age. However, safety and efficacy of micafungin infection have not been established for the treatment of candidemia with meningoencephalitis or ocular dissemination in children younger than 4 months of age.
